Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-β1 and IL-6

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Ruff, Kristin R ^a   Puetter, Adriane ^a   Levy, Laura S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GENOMIC DNA; INTERLEUKIN 6; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

AIDS RELATED COMPLEX; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL POPULATION; COLORIMETRY; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVATION; FLOW CYTOMETRY; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLASTIC LYMPHOMA; MOLECULAR DYNAMICS; NONHODGKIN LYMPHOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SIMIAN VIRUS;

ANIMALS; APOPTOSIS; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; LYMPHOMA, AIDS-RELATED; MACACA; RETROVIRUSES, SIMIAN; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33847781809     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-35     Document Type: Article

References (55)

1. Goedert JJ The epidemiology of acquired immunodeficiency syndrome malignancies Semin Oncol 2000 27 4 390-401 10950365
2. Levine AM Seneviratne L Espina BM Wohl AR Tulpule A Nathwani BN Gill PS Evolving characteristics of AIDS-related lymphoma Blood 2000 96 13 4084-4090 11110677
3. Carbone A Gloghini A AIDS-related lymphomas: From pathogenesis to pathology Br J Haematol 2005 130 5 662-670 16115121
4. Gaidano G Capello D Carbone A The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis Semin Oncol 2000 27 4 431-441 10950370
5. Diamond C Taylor TH Aboumrad T Anton-Culver H Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Incidence, presentation, treatment, and survival Cancer 2000 106 1 128-135
6. Baskin GB Murphey-Corb M Watson EA Martin LN Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta Vet Pathol 1988 25 6 456-467 2850650
7. Habis A Baskin GB Murphey-Corb M Levy LS Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulales the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma AIDS Res Hum Retroviruses 1999 15 15 1389-1398 10515154
8. Baskin GB Cremer KJ Levy LS Comparative pathobiology of HIV- and SIV-associated lymphoma AIDS Res Hum Retroviruses 2001 17 8 745-751 11429114
9. Habis A Baskin G Simpson L Fortgang I Murphey-Corb M Levy LS Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque AIDS Res Hum Retroviruses 2000 16 2 163-171 10659055
10. Jazirehi AR Bonavida B Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: Implications in chemosensitization and therapeutic intervention Oncogene 2005 24 13 2121-2143 15789036
11. Knowles DM Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma Hematol Oncol Clin North Am 2003 17 3 785-820 12852656
12. Wood C Harrington W Jr AIDS and associated malignancies Cell Res 2005 15 11-12 947-952 16354573
13. Fassone L Gaidano G Ariatti C Vivenza D Capello D Gloghini A Cilia AM Buonaiuto D Rossi D Pastore C The role of cytokines in the pathogenesis and management of AIDS- related lymphomas Leuk Lymphoma 2000 38 5-6 481-488 10953968
14. Hannig H Matz-Rensing K Kuhn EM Stahl-Hennig C Kaup FJ Hunsmann G Bodemer W Cytokine gene transcription in simian immunodeficiency virus and human immunodeficiency virus-associated non-Hodgkin lymphomas AIDS Res Hum Retroviruses 1997 13 18 1589-1596 9430251
15. Emilie D Coumbaras J Raphael M Devergne O Delecluse HJ Gisselbrecht C Michiels JF Van Damme J Taga T Kishimoto T Interleukin-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients Blood 1992 80 2 498-504 1320956
16. Marsh JW Herndier B Tsuzuki A Ng VL Shiramizu B Abbey N McGrath MS Cytokine expression in large cell lymphoma associated with acquired immunodeficiency syndrome J Interferon Cytokine Res 1995 15 3 261-268 7584673
17. Pastore C Gaidano G Ghia P Fassone L Cilla AM Gloghini A Capello D Buonaiuto D Gonella S Roncella S Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma BrJ Haematol 1998 103 1 143-149
18. Alas S Bonavida B Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis Clin Cancer Res 2003 9 1 316-326 12538484
19. Alas S Emmanouilides C Bonavida B Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin Cancer Res 2001 7 3 709-723 11297268
20. Buske C Hannig H Schneider EM Blaschke S Hunsmann G Bodemer W Hiddemann W Transforming growth factor beta is a growth-inhibitory cytokine of B cell lymphoma in SIV-infected macaques AIDS Res Hum Retroviruses 1999 15 16 1477-1485 10555111
21. DeCoteau JF Knaus Pl Yankelev H Reis MD Lowsky R Lodish HF Kadin ME Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlatos with insensitivity to TGF-beta in chronic lymphocytic leukemia Proc Natl Acad Sci USA 1997 94 11 5877-5881 20874 9159168
22. Douglas RS Capocasale RJ Lamb RJ Nowell PC Moore JS Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta Blood 1997 89 3 941-947 9028325
23. Kim SJ Letterio J Transforming growth factor-beta signaling in normal and malignant hematopoiesis Leukemia 2003 17 9 1731-1737 12970772
24. Fukuda M Longnecker R Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway J Virol 2004 78 4 1697-1705 369507 14747535
25. Mori N Morishita M Tsukazaki T Yamamoto N Repressionof Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB Int J Cancer 2003 105 5 661-668 12740915
26. Heinrich PC Behrmann L Haan S Hermanns HM Muller-Newen G Schaper F Principies of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 2003 374 Pt 1 1-20 1223585 12773095
27. Hirano T Ishihara K Hibi M Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors Oncogene 2000 19 21 2548-2556 10851053
28. Kamimura D Ishihara K Hirano T IL-6 signal transduction and its physiological roles: The signal orchestration model Rev Physiol Biochem Pharmacol 2003 149 1-38 12687404
29. Chen RH Chang MC Su YH Tsai YT Kuo ML Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways J Biol Chem 1999 274 33 23013-23019 10438468
30. Athas GB Choi B Prabhu S Lobelle-Rich PA Levy LS Genetic determinants of feline leukemia virus-induced multicentric lymphomas Virology 1995 214 2 431-438 8553544
31. Blaschke S Hannig H Buske C Kaup FJ Hunsmann G Bodemer W Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques J Med Virol 2001 65 1 114-120 11505452
32. Barna G Sebestyen A Chinopoulos CC Nagy K Mihalik R Paku S Kopper L TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8 Anticancer Res 2002 22 6C 3867-3872 12553006
33. Chaouchi N Arvanitakis L Auffredou MT Blanchard DA Vazquez A Sharma S Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines Oncogene 1995 11 8 1615-1622 7478586
34. Inman GJ Allday MJ Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent J Immunol 2000 165 5 2500-2510 10946276
35. Kuo ML Chuang SE Lin MT Yang SY The involvement of Pl 3-K/Akt- dependent up-regulation of Mcl-1 in the prevention of apoptosis of HepSB cells by interleukin-6 Oncogene 2001 20 6 677-685 11314001
36. Wei LH Kuo ML Chen CA Chou CH Cheng WF Chang MC Su JL Hsieh CY The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a Pl 3-K/Akt pathway Oncogene 2001 20 41 5799-5809 11593385
37. Bellan C De Falco G Lazzi S Leoncini L Pathologie aspects of AIDS malignancies Oncogene 2003 22 42 6639-6645 14528289
38. Fukada T Hibi M Yamanaka Y Takahashi-Tezuka M Fujitani Y Yamaguchi T Nakajima K Hirano T Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis Immunity 1996 5 5 449-460 8934572
39. Bromberg J Darnell JE Jr The role of STATs in transcriptional control and their impact on cellular function Oncogene 2000 19 21 2468-2473 10851045
40. Buettner R Mora LB Jove R Activated STAT signaling in human tumors provides novel molecular targets for therapeutic Intervention Clin Cancer Res 2002 8 4 945-954 11948098
41. Catlett-Falcone R Landowski TH Oshiro MM Turkson J Levitzki A Savino R Ciliberto G Moscinski L Fernandez-Luna JL Nunez G Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells Immunity 1999 10 1 105-115 10023775
42. Fernandas A Hamburger AW Gerwin BI ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells Int J Cancer 1999 83 4 564-570 10508495
43. Gao B Shen X Kunos G Meng Q Goldberg ID Rosen EM Fan S Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells FEBS Lett 2001 488 3 179-184 11163768
44. Garcia R Bowman TL Niu G Yu H Minton S Muro-Cacho CA Cox CE Falcone R Fairclough R Parsons S Constitutive activation of StatS by the Src and JAK tyrosine kinases participales in growth regulation of human breast carcinoma cells Oncogene 2001 20 20 2499-2513 11420660
45. Lin TS Mahajan S Frank DA STAT signaling in the pathogenesis and treatment of leukemias Oncogene 2000 19 21 2496-2504 10851048
46. Weber-Nordt RM Egen C Wehinger J Ludwig W Gouilleux-Gruart V Mertelsmann R Finke J Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines Blood 1996 88 3 809-816 8704235
47. Derenne S Monia B Dean NM Taylor JK Rapp MJ Harousseau JL Bataille R Amiot M Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells Blood 2002 100 1 194-199 12070027
48. Puthier D Derenne S Barille S Moreau P Harousseau JL Bataille R Amiot M Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells Br J Haematol 1999 107 2 392-395 10583232
49. Epling-Burnette PK Liu JH Catlett-Falcone R Turkson J Oshiro M Kothapalli R Li Y Wang JM Yang-Yen HF Karras J Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression J Clin Invest 2001 107 3 351-362 199188 11160159
50. Lomo J Smeland EB Krajewski S Reed JC Blomhoff HK Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes Cancer Res 1996 56 1 40-43 8548771
51. Han J Goldstein LA Gastman BR Rabinowich H Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis J Biol Chem 2006 281 15 10153-10163 16478725
52. Weng C Li Y Xu D Shi Y Tang H Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)- induced apoptosis in Jurkat leukemia T cells J Biol Chem 2005 280 11 10491-10500 15637055
53. Ng VL Hurt MH Fein CL Khayam-Bashi F Marsh J Nunes WM McPhaul LW Feigal E Nelson P Herndier BG IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis Blood 1994 83 4 1067-1078 8111047
54. Komanduri KV Luce JA McGrath MS Herndier BG Ng VL The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions J Acquir Immune Defic Syndr Hum Retrovirol 1996 13 3 215-226 8898666
55. Renne R Blackbourn D Whitby D Levy J Ganem D Limited transmission of Kapos i's sarcoma-associated herpesvirus in cultured cells J Virol 1998 72 6 5182-5188 110093 9573290